Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Michigan updates school and quarantine guidance
United States | Publication | January 18, 2022
In early-December 2021, the Michigan Department of Health and Human Services announced its streamlined guidance to help prevent transmission of COVID among students while reducing disruptions to in-person learning. The Department stated, “[i]n addition to vaccination, which is approved for ages five and up, layered prevention measures, including masking, should be put in place for consistent in-person learning to keep kids, staff and families safe.”
The state recommends that local health departments and the schools “work together to quickly isolate COVID cases among students and staff, identify close contacts of those cases, and adopt quarantine policies that reduce the risk of transmission in schools while allowing in-person learning.” The assumption is that when measures such as vaccination, masking, distancing and testing are utilized, students exposed to COVID may not have to quarantine at home and can stay in the classroom. Universal masking in the K–12 setting remains the recommendation.
Additional guidance for the exposed provides that those who are fully-vaccinated without symptoms do not need to quarantine.
Recent publications
Publication
African nations need to present a united front at COP29 to ensure their voices are heard
Africa faces a stark reality: contributing less than 4% of global greenhouse gas emissions, the continent is disproportionately impacted by climate change, threatening its development and stability.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .